A Study of the Efficacy and Safety of CF101 to Patients With Osteoarthritis of the Knee

NCT00837291 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped The company has decided not to conduct the study

Conditions

Osteoarthritis of the Knee

Interventions

DRUG: CF101
DRUG: Placebo

Sponsor

Can-Fite BioPharma